‬‬Samira Alesaeidi

772 total citations · 1 hit paper
36 papers, 512 citations indexed

About

‬‬Samira Alesaeidi is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, ‬‬Samira Alesaeidi has authored 36 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Rheumatology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Physiology. Recurrent topics in ‬‬Samira Alesaeidi's work include Vasculitis and related conditions (8 papers), Systemic Lupus Erythematosus Research (6 papers) and Sarcoidosis and Beryllium Toxicity Research (5 papers) ‬‬Samira Alesaeidi is often cited by papers focused on Vasculitis and related conditions (8 papers), Systemic Lupus Erythematosus Research (6 papers) and Sarcoidosis and Beryllium Toxicity Research (5 papers) ‬‬Samira Alesaeidi collaborates with scholars based in Iran, United States and Poland ‬‬Samira Alesaeidi's co-authors include Sepideh Miraj, Soheil Tavakolpour, Mahdieh Abbasalizad Farhangi, Mohammad Darvishi, Meisam Akhlaghdoust, Morteza Akbari, Navid Shomali, Majid Zamani, Sahar Kiani and M. V. Mikhailova and has published in prestigious journals such as SHILAP Revista de lepidopterología, Stem Cell Research & Therapy and Lupus.

In The Last Decade

‬‬Samira Alesaeidi

31 papers receiving 488 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Screen time increases overweight and obesity risk among adolescents: a systematic review and dose-response meta-analysis

2022 73 citations Mahdieh Abbasalizad Farhangi, ‬‬Samira Alesaeidi et al. BMC Primary Care profile →

Peers

‬‬Samira Alesaeidi

RHEUM

IMMUN

PHEOH

PHYSI

Fatemeh Mohseni Iran

D Brănişteanu Romania

Faisal R. Ali United Kingdom

Liming Tao China

Weiwei Sun China

Gema Doménech Spain

Jingyi Li China

Min Tang China

Serap Güneş Bilgili Türkiye

Yang-Shia Dai Taiwan

Fatemeh Mohseni Iran

‬‬Samira Alesaeidi

77 ×0.7

85 ×0.9

RHEUM

38 ×0.6

IMMUN

97 ×1.6

PHEOH

60 ×1.0

PHYSI

Citations per year, relative to ‬‬Samira Alesaeidi ‬‬Samira Alesaeidi (= 1×) peers Fatemeh Mohseni

Countries citing papers authored by ‬‬Samira Alesaeidi

Since Specialization

Citations

This map shows the geographic impact of ‬‬Samira Alesaeidi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ‬‬Samira Alesaeidi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ‬‬Samira Alesaeidi more than expected).

Fields of papers citing papers by ‬‬Samira Alesaeidi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by ‬‬Samira Alesaeidi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ‬‬Samira Alesaeidi. The network helps show where ‬‬Samira Alesaeidi may publish in the future.

Co-authorship network of co-authors of ‬‬Samira Alesaeidi

This figure shows the co-authorship network connecting the top 25 collaborators of ‬‬Samira Alesaeidi. A scholar is included among the top collaborators of ‬‬Samira Alesaeidi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with ‬‬Samira Alesaeidi. ‬‬Samira Alesaeidi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alesaeidi, ‬‬Samira, et al.. (2024). Significant heightened methylation levels of RUNX3 gene promoter in patients with systemic lupus erythematosus. Lupus. 33(6). 547–554. 3 indexed citations

Alesaeidi, ‬‬Samira, et al.. (2024). Clinical Manifestations of Wegener Granulomatosis in Iranian Ethnicities Using the K-Means Algorithm: A Descriptive Study. International Archives of Otorhinolaryngology. 28(1). e83–e94. 1 indexed citations

Zhao, Peng, et al.. (2023). Nano-Liposome Co-Loaded with C-X-C Chemokine Ligand 12/CXCR4 Pathway Inhibitor Synergistically Increases the Immune Efficacy of Anti-PD-L1 and Increase Anti-Tumor Activity of Effector T Cells. Journal of Biomedical Nanotechnology. 19(5). 823–833. 1 indexed citations

Effatpanah, Mohammad, et al.. (2023). The predictive role of personality traits and demographic features on post-traumatic stress disorder in a sample of COVID-19 hospitalized patients. Middle East Current Psychiatry. 30(1). 1 indexed citations

Alesaeidi, ‬‬Samira, et al.. (2023). Demethylation of CDKN2A in systemic lupus erythematosus and rheumatoid arthritis: a blood biomarker for diagnosis and assessment of disease activity. Clinical Rheumatology. 42(12). 3387–3395. 5 indexed citations

Tavakolpour, Soheil, et al.. (2023). Neurologic Involvement in Granulomatosis with Polyangiitis: A Comparative Study. SHILAP Revista de lepidopterología. 19–19.

Alesaeidi, ‬‬Samira, et al.. (2023). The therapeutic effects of mesenchymal stem cell (MSCs) exosomes in covid-19 disease; Focusing on dexamethasone therapy. Pathology - Research and Practice. 251. 154815–154815. 1 indexed citations

Alesaeidi, ‬‬Samira, et al.. (2022). Predictors of relapse in granulomatosis with polyangiitis: a multi-center study. SHILAP Revista de lepidopterología. 49(1). 1 indexed citations

Farhangi, Mahdieh Abbasalizad, et al.. (2022). Screen time increases overweight and obesity risk among adolescents: a systematic review and dose-response meta-analysis. BMC Primary Care. 23(1). 161–161. 73 indexed citations breakdown →

10.

Alesaeidi, ‬‬Samira, et al.. (2022). A functional microRNA binding site variant in IL-23R gene in systemic lupus erythematosus and rheumatoid arthritis: is there any correlation?. Molecular Biology Reports. 49(12). 11821–11828. 3 indexed citations

11.

Yazdi, Niloofar Ayoobi, et al.. (2022). Predicting factors for relapse in patients with granulomatosis with polyangiitis: results from a long-term cohort. Clinical Rheumatology. 41(8). 2457–2465. 2 indexed citations

12.

Alesaeidi, ‬‬Samira, et al.. (2022). miRNA-binding site polymorphism in IL-15RA gene in rheumatoid arthritis and systemic lupus erythematosus: correlation with disease risk and clinical characteristics. Clinical Rheumatology. 41(11). 3487–3494. 2 indexed citations

13.

Alesaeidi, ‬‬Samira, et al.. (2022). Analysis of SDC2 gene promoter methylation in whole blood for noninvasive early detection of colorectal cancer. Journal of Cancer Research and Therapeutics. 18(Suppl 2). S354–S358. 6 indexed citations

14.

Masoumi, Maryam, et al.. (2022). Role of T Cells in the Pathogenesis of Rheumatoid Arthritis: Focus on Immunometabolism Dysfunctions. Inflammation. 46(1). 88–102. 22 indexed citations

15.

Alesaeidi, ‬‬Samira, et al.. (2022). A comprehensive review about the utilization of immune checkpoint inhibitors and combination therapy in hepatocellular carcinoma: an updated review. Cancer Cell International. 22(1). 269–269. 8 indexed citations

16.

Alesaeidi, ‬‬Samira, et al.. (2022). The association between dietary glycemic index and cardio-metabolic risk factors in obese individuals. BMC Nutrition. 8(1). 114–114. 1 indexed citations

17.

Tavakolpour, Soheil, et al.. (2019). A comprehensive review of rituximab therapy in rheumatoid arthritis patients. Clinical Rheumatology. 38(11). 2977–2994. 90 indexed citations

18.

Miraj, Sepideh & ‬‬Samira Alesaeidi. (2016). A systematic review study of therapeutic effects of Matricaria recuitta chamomile (chamomile). SHILAP Revista de lepidopterología. 8(9). 3024–3031. 86 indexed citations

19.

Alesaeidi, ‬‬Samira & Sepideh Miraj. (2016). A Systematic Review of Anti-malarial Properties, Immunosuppressive Properties, Anti-inflammatory Properties, and Anti-cancer Properties of Artemisia Annua. SHILAP Revista de lepidopterología. 8(10). 3150–3155. 38 indexed citations

20.

Alesaeidi, ‬‬Samira, Jafar Karami, Mahdi Mahmoudi, et al.. (2015). Methyl-CpG-Binding Protein 2 (MECP2) Polymorphism in Iranian Patients with Systemic Lupus Erythematosus. Inflammation. 38(6). 2185–2190. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact